Compare Bintang Samudera Mandiri Lines Tbk (BSML) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bintang Samudera Mandiri Lines Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bintang Samudera Mandiri Lines Tbk trades at Rp520 (market cap 952.87B, 18.7M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Bintang Samudera Mandiri Lines Tbk is far larger — about 5.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bintang Samudera Mandiri Lines Tbk is more actively traded (18.7M versus 71K). Which is the better fit depends on your goals.
| BSML | OBAT | |
|---|---|---|
Market Cap | 952.87B | 167.37B |
Volume | 18.7M | 71K |
Lot | 187.04K | 710 |
Turnover | 9.68B | 17.51M |
Average Price | 517.75 | 246.63 |
Value | 9.68B | 17.51M |
Indicative Equilibrium Price | 520 | 246 |
Indicative Equilibrium Volume | 31 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bintang Samudera Mandiri Lines Tbk
PT Bintang Samudera Mandiri Lines Tbk (the Company) was established based on Notarial Deed No. 101 of Fransiskus Djoenardi, S.H., dated November 17, 2007. The Company has started its operations since 2017.
Read more on BSML →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
